Expression of basic fibroblast growth factor in squamous cell carcinomas of the larynx - Examination by in situ hybridization

Onkologie

Volumn 22, Issue 1, 1999, Pages 41-46

  Quint, C ^a   Neuchrist, C ^b   Breitschopf, H ^b   Pammer, J ^a   Burian, M ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b HNO Universitätsklinik ^*

Author keywords

Basic fibroblast growth factor; BFGF; Carcinoma of the larynx

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CD34 ANTIGEN; VASCULOTROPIN;

ARTICLE; CLINICAL ARTICLE; ENDOTHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARYNX CARCINOMA; MACROPHAGE; NEOVASCULARIZATION (PATHOLOGY); PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STAINING; TUMOR VASCULARIZATION;

EID: 0033014196     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026915     Document Type: Article

References (44)

1. Vartanian R, Weidner N: Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol 1994;144: 1188-1194.
2. Weidner N, Folkman J, Pozza F, Bevilaqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: A new significant and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-1887.
3. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82:4-6.
4. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-364.
5. Folkman J: The role of angiogenesis in tumor growth. Semin Cancer Biol 1992;3:65-71.
6. Klagsbrun M: Angiogenesis; in Sporn MB, Roberts AB (eds): Handbook of Experimental Pharmacology. Berlin, Springer, 1990, vol 95/2, pp 549-586.
7. Blood CH, Zetter BR: Tumor interactions with the vasculature: Angiogenesis and tumor metastasis. Biochim Biophys Acta 1990;1032:89-118.
8. Basilico C, Moscatelli D: The FGF family of growth factors and oncogenes; in Vande Voude GF, Klein G (eds): Advances in Cancer Research. New York, Academic Press, 1992, pp 115-165.
9. Partridge M, Kiguwa S, Luqmani Y, Langdon JD: Expression of bFGF, KGF and FGF receptors on normal oral mucosa and SCC. Eur J Cancer, Part B: Oral Oncol 1996;328:76-82.
10. Baird A, Klagsbrun M (eds): The fibroblast growth factor family. Ann NY Acad Scei 1991;638:1-515.
11. Cordon-Cardo C, Vlodavsky I, Haimovitz-Friedman A, Hicklin D, Fuks Z: Expression of basic fibroblast growth factor in normal human tissues. Lab Invest 1990;63:832-840.
12. Friess H, Korc M, Büchler MW: Molekularbiologie beim Pankreaskarzinom: Überexpression von Fibroblast Growth Factors. Chirurg 1994;65:604-610.
13. Ueki T, Koji T, Tamiya S, Nakane P, Tsuneyoshi M: Expression of basic fibroblast growth factor and fibroblast growth factor receptor in advanced gastric carcinoma. J Pathol 1995;177:353-361.
14. Li D, Bell J, Brown A, Berry CL: The observation of angiogenin and basic fibroblast growth factor gene expression in human colonic adenocarcinomas. gastric adenocarcinomas, and hepatocellular carcinomas. J Pathol 1994;172:171-175.
15. Schweiger L, Neufeld G, Mergia A, Abraham JA, Fiddes JC, Gospodarowicz D: Basic fibroblast growth factor in human rhabdomyosarcoma cells: Implications for the proliferation and neovascularization of myoblast-derived tumors. Proc Natl Acad Sci USA 1987;84:842-846.
16. Mattern J, Koomägi R, Volm M: Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. Anticancer Res 1997;17:2249-2252.
17. Mise M, Arii S, Higashituji H, Furutani M, Niwano M. Harada T, Ishigami S, Toda Y, Nakayama H, Fukumoto M, Fujita J, Imamura M: Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology 1996;23:455-464.
18. Morrison RS, Gross JL, Herblin WF, Reilly TM, LaSala PA, Alterman RL, Moskal JR, Kornblith PL, Dexter DL: Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. Cancer Res 1990;50:2524-2529.
19. Shanmugaratnam K, Sobin LH: Histological typing of upper respiratory tract tumours. WHO, Geneva, pp 14, 33.
20. Breitschopf H, Suchanek G, Gould RM, Colman DR, Lassmann H: In situ hybridization with digoxigenin-labeled probes: Sensitive and reliable detection method applied to myelinating rat brain. Acta Neuropathol 1992;84:581-587.
21. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
22. Carter RL: Pathology of squamous carcinoma of the head and neck. Curr Opin Oncol 1991;3:507-511.
23. Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M: Heparin affinity: Purification of a tumor-derived capillary endothelial cell growth factor. Science 1984;223:1296-1298.
24. Schultz-Hector S, Haghayegh S: Basic fibroblast growth factor expression in human and murine squamous cell carcinomas and its relationship to regional endothelial cell proliferation. Cancer Res 1993;53:1444-1449.
25. Thomas GR, Tubb EE, Sessions RB, Cullen KJ: Growth factor mRNA expression in human head and neck malignant tumors. Arch Otolaryngol Head Neck Surg 1993;119:1247-1252.
26. Janot F, El-Naggar AK, Morrison RS, Liu T-J, Taylor DL, Clayman GL: Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation. Int J Cancer 1995;64:117-123.
27. Hughes CJ, Reed JA, Cabal R, Huvos AG, Albino AP, Schantz SP: Increased expression of basic fibroblast growth factor in squamous carcinogenesis of the head and neck is less prevalent following smoking cessation. Am J Surg 1994;168:381-385.
28. Petruzzelli GJ, Benefield J, Taitz AD, Fowler S, Kalkanis J, Scobercea S, West D, Young MRI: Heparin-binding growth factor(s) derived from head and neck squamous cell carcinomas induce endothelial cell proliferation. Head Neck 1997;19:576-582.
29. Dellacono FR, Spiro J, Eisma R, Kreutzer D: Expression of basic fibroblast growth factor and its receptors by head and neck squamous carcinoma tumor and vascular endothelial cells. Am J Surg 1997;174:540-544.
30. Knerer B, Formanek M, Schickinger B, Martinek H, Kornfehl J: Different KGF expression in squamous cell carcinomas of the head and neck and in normal mucosa. Acta Otolaryngol 1997;117.
31. Singh RK, Gutman M, Bucana CD, Sanchez R, Llansa N, Fidler IJ: Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci USA 1995;92:4562-4566.
32. Abraham JA, Whang JL, Tumolo A, Mergia A, Friedman J, Gospodarowicz D, Fiddes JC: Human basic fibroblast growth factor: Nucleotide sequence and genomic organization. EMBO J 1986;5: 2523-2528.
33. Saksela O, Moscatelli D, Sommer A, Rifkin DB: Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol 1988;107:743-751.
34. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I: A heparin-binding angiogenic protein, basic fibroblast growth factor, is stored within basement membrane. Am J Pathol 1988;130:393-400.
35. Czubayko F, Smith RV, Chung HC, Wellstein A: Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J Biol Chem 1994;269:28243-28248.
36. Czubayko F, Liaudet-Coopman EDE, Aigner A, Tuveson AT, Berchem GJ, Wellstein A: A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nat Med 1997;3:1137-1140.
37. Folkman J, Shing Y: Angiogenesis. J Biol Chem 1992;267:10931-10934.
38. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993;362:841-844.
39. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by dominant-negative Flk-1 mutant. Nature 1994;367: 576-579.
40. Eisma RJ, Spiro JD, Kreutzer DL: Vascular endothelial growth factor expression in head and neck squamous cell carcinoma. Am J Surg 1997;174: 513-517.
41. Salven P, Heikkila P, Anttonen A, Kajanti M, Joensuu H: Vascular endothelial growth factor in squamous cell head and neck carcinoma: Expression and prognostic significance. Mod Pathol 1997;10:1128-1133.
42. Haynes LW: Fibroblast (heparin-binding) growing factors in neuronal development and repair. Mol Neurobiol 1988;2:263-289.
43. Reidy MA, Fingerle J, Lindner V: Factors controlling development of arterial lesions after injury. Circulation 1992;86:suppl 6, III, pp 43-46.
44. Steenfos HH: Growth factors and wound healing. Scand J Plast Reconstr Surg Hand Surg 1994;28: 95-105.